CGEM vs XOM · $830.3M cap vs P/E 24, rev $332.24B
Cullinan Oncology LLC (CGEM) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE. It is led by Darren Woods.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
Latest reported XOM revenue for 2025-12-31 was $332.24B. Net income was $28.84B. Revenue was down 5.0% from 2024-12-31 to 2025-12-31. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
CGEM currently screens at market cap $830.3M. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the CGEM and XOM stock pages for the full models.
Not investment advice.